Back to results
US 11,590,140 B1Granted
Formulation for alleviating veisalgia symptoms
AssigneePSR Brands, LLC
InventorsJason Kelly Allison, Guillermo A. Amtmann, John Burton Steele
Life of this patent
Estimating the term…
Abstract
The embodiments of the present disclosure generally relate to a formulation for alleviating veisalgia symptoms. The formulation can comprise anhydrous caffeine, salicin, and valerian. The components can be delivered within a liquid medium and act synergistically to more effectively relieve veisalgia symptoms than when taken individually.
Claims13
A formulation comprising:
- a. anhydrous caffeine;
- b. salicin;
- and
- c. valerian;
- and
- wherein the relative weight ratios of anhydrous caffeine:salicin:valerian is 1:1.2-3.8:2.5-8, and
- wherein the components act synergistically to alleviate veisalgia symptoms.
4 more elements
A formulation comprising:
- a. anhydrous caffeine;
- b. salicin;
- c. valerian;
- and
- d. ginger;
- wherein the relative weight ratios of anhydrous caffeine:salicin:valerian is 1:1.2-3.8:2.5-8, and
- wherein the components act synergistically to alleviate veisalgia symptoms.
4 more elements
A formulation comprising:
- a. anhydrous caffeine;
- b. salicin;
- c. valerian;
- d. magnesium chloride;
- e. ginger;
- f. calcium lactate;
- g. trisodium citrate;
- and
- h. potassium citrate
- wherein the relative weight ratios of anhydrous caffeine:salicin:valerian:magnesium chloride:ginger:calcium lactate:trisodium citrate:potassium citrate is about 1:1.2-3.8:2.5-8:0.1-0.4:1:0.3-1.5:10-35:3-10.
7 more elements
Dependencies are inferred from the claim text.